1,061
Views
85
CrossRef citations to date
0
Altmetric
Original Article

Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population

, , &
Pages 1169-1174 | Accepted 15 Mar 2011, Published online: 06 Apr 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Jielin Yang, XiaoJu Li, Lu Mao, Jiaxin Dong, Rong Fan & Liwen Zhang. (2023) Path Analysis of Influencing Factors of Depression in Middle-Aged and Elderly Patients with Diabetes. Patient Preference and Adherence 17, pages 273-280.
Read now
Samaneh Kalirai, Jasmina I Ivanova, Magaly Perez-Nieves, Judith J Stephenson, Irene Hadjiyianni, Michael Grabner, Roy Daniel Pollom, Caroline Geremakis, Beverly L Reed & Lawrence Fisher. (2020) Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States. Diabetes, Metabolic Syndrome and Obesity 13, pages 1023-1033.
Read now
Kenneth S Hershon. (2016) Options for empagliflozin in combination therapy in type 2 diabetes mellitus. International Journal of General Medicine 9, pages 155-172.
Read now
Matthew Riddle, Anne Peters & Martha Funnell. (2016) Increasing Patient Acceptance and Adherence Toward Insulin. Postgraduate Medicine 128:sup1, pages 11-20.
Read now
Masato Odawara, Hitoshi Ishii, Naoko Tajima & Yasuhiko Iwamoto. (2016) Impact of patient attitudes and beliefs to insulin therapy upon initiation, and their attitudinal changes after initiation: the DAWN Japan study. Current Medical Research and Opinion 32:4, pages 681-686.
Read now
Dilek Gogas Yavuz, Sevim Ozcan & Oguzhan Deyneli. (2015) Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens. Patient Preference and Adherence 9, pages 1225-1231.
Read now
Christopher Sorli & Michael K Heile. (2014) Identifying and meeting the challenges of insulin therapy in type 2 diabetes. Journal of Multidisciplinary Healthcare 7, pages 267-282.
Read now
Mayme Wong, Radhi Abdulnabi, Michelle A. Carey & Haoda Fu. (2013) A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes. Current Medical Research and Opinion 29:5, pages 465-473.
Read now

Articles from other publishers (77)

Elizabeth Holmes‐Truscott, Edith E. Holloway, Benjamin Lam, Shaira Baptista, John Furler, Virginia Hagger, Timothy Skinner & Jane Speight. (2023) ‘Is Insulin Right for Me?’: Web‐based intervention to reduce psychological barriers to insulin therapy among adults with non‐insulin‐treated type 2 diabetes—A randomised controlled trial. Diabetic Medicine 40:7.
Crossref
David J. Robinson, Kimberley Hanson, Akshay B. Jain, Jessica C. Kichler, Gaurav Mehta, Osnat C. Melamed, Michael Vallis, Harpreet S. Bajaj, Tracy Barnes, Jeremy Gilbert, Kristin Honshorst, Robyn Houlden, James Kim, Joanne Lewis, Barbara MacDonald, Dylan MacKay, Kerry Mansell, Doreen Rabi, Diana Sherifali & Peter Senior. (2023) Diabetes and Mental Health. Canadian Journal of Diabetes 47:4, pages 308-344.
Crossref
Weixi Kang. (2022) Investigating the association between diabetes and mental health: A train-and-test approach. Frontiers in Psychiatry 13.
Crossref
Guangxin Han, Shanshan Hu, Xiaoning Zhang, Zhikun Qiu & Zhe Huang. (2022) Insulin degludec/liraglutide versus its monotherapy on T2D patients: A lifetime cost-utility analysis in China. Frontiers in Pharmacology 13.
Crossref
Maya Allen-Taylor, Laura Ryan, Kirsty Winkley & Rebecca Upsher. (2022) Exploring the Experiences and Perspectives of Insulin Therapy in Type 2 Diabetes via Web-Based UK Diabetes Health Forums: Qualitative Thematic Analysis of Threads. JMIR Diabetes 7:4, pages e34650.
Crossref
Kentaro Okazaki, Noriyuki Takahashi, Tomotaka Shingaki, Magaly Perez-Nieves & Heather Stuckey. (2022) Key factors for overcoming psychological insulin resistance: A qualitative study in Japanese people with type 2 diabetes. Primary Care Diabetes 16:3, pages 411-416.
Crossref
Rebecca N. Adams, Shaminie J. Athinarayanan, Amy L. McKenzie, Sarah J. Hallberg, James P. McCarter, Stephen D. Phinney & Jeffrey S. Gonzalez. (2022) Depressive symptoms improve over 2 years of type 2 diabetes treatment via a digital continuous remote care intervention focused on carbohydrate restriction. Journal of Behavioral Medicine 45:3, pages 416-427.
Crossref
Qingxiu Tian, Rebecca Upsher & Kirsty Winkley. (2022) Systematic review and meta-analysis of diabetes specialist delivered insulin education for adults with type 2 diabetes in outpatient settings. Patient Education and Counseling 105:4, pages 835-842.
Crossref
Elizabeth Holmes‐Truscott, Edith E. Holloway, Hanafi M. Husin, John Furler, Virginia Hagger, Timothy C. Skinner & Jane Speight. (2021) ‘Is insulin right for me?’: Feasibility of a pilot randomised controlled trial and acceptability of a web‐based intervention to reduce psychological barriers to insulin therapy among adults with type 2 diabetes. Diabetic Medicine 39:3.
Crossref
Elizabeth Holmes-Truscott, Edith E Holloway, Hanafi M Husin, John Furler, Virginia Hagger, Timothy C Skinner & Jane Speight. (2022) Web-based intervention to reduce psychological barriers to insulin therapy among adults with non-insulin-treated type 2 diabetes: study protocol for a two-armed randomised controlled trial of ‘ Is insulin right for me? ’ . BMJ Open 12:2, pages e051524.
Crossref
Elizabeth Holmes‐Truscott, Jasmine Schipp, Trisha Dunning, John Furler, Virginia Hagger, Edith E. Holloway, Jo‐Anne Manski‐Nankervis, Jonathan E. Shaw, Timothy Skinner & Jane Speight. (2021) ‘For me, it didn’t seem as drastic a step as being controlled by insulin’: A qualitative investigation of expectations and experiences of non‐insulin injectable therapy among adults with type 2 diabetes. Diabetic Medicine 39:2.
Crossref
Jae Hyun Bae, Chang Ho Ahn, Ye Seul Yang, Sun Joon Moon, Soo Heon Kwak, Hye Seung Jung, Kyong Soo Park & Young Min Cho. (2022) Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial. Diabetes & Metabolism Journal 46:1, pages 71-80.
Crossref
Kevser IŞIK, Hilal YILDIRIM & Zeliha CENGİZ. (2021) Diyabetli Hastalarda Psikolojik İnsülin Direnci Ölçeğinin Türkçeye UyarlanmasıTurkish Adaptation of Psychological Insulin Resistance Scale in Diabetic Patients. Turkish Journal of Family Medicine and Primary Care 15:4, pages 726-733.
Crossref
Yeon Jeong Jang. (2021) Psychological Insulin Resistance: Key Factors and Intervention. The Journal of Korean Diabetes 22:3, pages 192-196.
Crossref
Edith E Holloway, Jane Speight, John Furler, Virginia Hagger, David N O'Neal, Timothy C Skinner & Elizabeth Holmes-Truscott. (2021) ‘Is Insulin Right for Me?’ Development of a theory-informed, web-based resource for reducing psychological barriers to insulin therapy in type 2 diabetes. BMJ Open 11:9, pages e045853.
Crossref
Noralina Zakaria, Narasimman Baskaran & Wan Lin Lim. (2021) Perception towards Insulin Therapy and Factors Related to Insulin Refusal among Insulin Naive Type 2 Diabetes Mellitus Patients in Primary Care Clinics PKD Lipis. Journal of Pharmacy 1:2, pages 70-78.
Crossref
Frank J. Snoek, Lawrence Fisher, William H. Polonsky, Heather Stuckey, Danielle Hessler, Tricia Tang, Norbert Hermanns, Xavier Mundet, Maria Silva, Jackie Sturt, Kentaro Okazaki, Irene Hadjiyianni, Urvi Desai & Magaly Perez-Nieves. (2021) Overcoming psychological insulin resistance: A practical guide for healthcare professionals. Primary Care Diabetes 15:3, pages 619-621.
Crossref
Ajoy Tiwari, Dinesh Kumar, Mohammad S. Ansari, Santosh Kumar Chaubey, Nitin R. Gupta, Vivek Agarwal, Kumar Prafull Chandra, Arunkumar r Pande, Rajiv Awasthi, Mukulesh Gupta & Sandeep Chowdhary. (2021) Impact of lockdown on self-care management among patients with type 2 Diabetes Mellitus residing in Lucknow city, India – A cross-sectional study. Clinical Epidemiology and Global Health 10, pages 100703.
Crossref
Ching-Chu Chen, Tsai-Chung Li, Chi-Yu Huang & Man-Ping Chang. (2020) Validation of the Chinese version of the insulin treatment appraisal scale. Diabetes Research and Clinical Practice 170, pages 108485.
Crossref
Elemer G. Balogh, Magaly Perez-Nieves, Dachuang Cao, Irene I. Hadjiyianni, Nadeem Ashraf, Urvi Desai, Frank J. Snoek & Jackie A. Sturt. (2020) Key Strategies for Overcoming Psychological Insulin Resistance in Adults with Type 2 Diabetes: The UK Subgroup in the EMOTION Study. Diabetes Therapy 11:8, pages 1735-1744.
Crossref
Sonia Mukhtar & Sakina Mukhtar. (2020) Letter to the Editor: Mental Health and Psychological Distress in People with Diabetes during COVID-19. Metabolism 108, pages 154248.
Crossref
Ioannis Avgerinos, Theodoros Michailidis, Aris Liakos, Thomas Karagiannis, David R. Matthews, Apostolos Tsapas & Eleni Bekiari. (2019) Oral semaglutide for type 2 diabetes: A systematic review and meta‐analysis. Diabetes, Obesity and Metabolism 22:3, pages 335-345.
Crossref
Susan J. Guzman. (2020) A Behavioral Perspective of Therapeutic Inertia: A Look at the Transition to Insulin Therapy. Diabetes Spectrum 33:1, pages 38-43.
Crossref
AsmaaM Alomran, DuaaA Almubarak, BatoolA Alrashed & AbdulS Khan. (2020) Psychological insulin resistance among type 2 diabetic patients attending primary healthcare centers, Al-Ahsa, Saudi Arabia. Journal of Family and Community Medicine 27:3, pages 192.
Crossref
Rebecca Upsher, Maya Allen-Taylor, Ilse Reece, Mark Chamley, Khalida Ismail, Angus Forbes & Kirsty Winkley. (2019) Experiences of Attending Group Education to Support Insulin Initiation in Type 2 Diabetes: A Qualitative Study. Diabetes Therapy 11:1, pages 119-132.
Crossref
Heather Stuckey, Lawrence Fisher, William H Polonsky, Danielle Hessler, Frank J Snoek, Tricia S Tang, Norbert Hermanns, Xavier Mundet-Tuduri, Maria Elizabeth Rossi da Silva, Jackie Sturt, Kentaro Okazaki, Dachuang Cao, Irene Hadjiyianni, Jasmina I Ivanova, Urvi Desai & Magaly Perez-Nieves. (2019) Key factors for overcoming psychological insulin resistance: an examination of patient perspectives through content analysis. BMJ Open Diabetes Research & Care 7:1, pages e000723.
Crossref
Hui-Chun HSU, Shi-Yu CHEN, Yu-Chi HUANG, Ruey-Hsia WANG, Yau-Jiunn LEE & Ling-Wang AN. (2019) Decisional Balance for Insulin Injection: Scale Development and Psychometric Testing. Journal of Nursing Research 27:5, pages e42.
Crossref
Kentaro Okazaki, Tomotaka Shingaki, Zhihong Cai, Magaly Perez-Nieves & Lawrence Fisher. (2019) Successful Healthcare Provider Strategies to Overcome Psychological Insulin Resistance in Japanese Patients with Type 2 Diabetes. Diabetes Therapy 10:5, pages 1823-1834.
Crossref
William H. Polonsky, Lawrence Fisher, Danielle Hessler, Heather Stuckey, Frank J. Snoek, Tricia Tang, Norbert Hermanns, Xavier Mundet, Maria Silva, Jackie Sturt, Kentaro Okazaki, Irene Hadjiyianni, Dachuang Cao, Jasmina Ivanova, Urvi Desai & Magaly Perez-Nieves. (2019) Identifying solutions to psychological insulin resistance: An international study. Journal of Diabetes and its Complications 33:4, pages 307-314.
Crossref
Olesya Y. Gurova, Valentin V. Fadeev & Ekaterina S. Maloletkina. (2019) Injectable therapy in type 2 diabetes mellitus: strategies to improve therapeutic adherence. Diabetes mellitus 21:6, pages 524-533.
Crossref
Xiaosu Bai, Zhiming Liu, Zhisen Li & Dewen Yan. (2018) The association between insulin therapy and depression in patients with type 2 diabetes mellitus: a meta-analysis. BMJ Open 8:11, pages e020062.
Crossref
Timothy M. E. Davis, Stephen A. P. Chubb, Bradley H. Curtis, Helen Barraclough & Wendy A. Davis. (2018) Temporal changes in glycaemic thresholds for treatment intensification in type 2 diabetes in an urban Australian setting: the Fremantle Diabetes Study. Internal Medicine Journal 48:10, pages 1215-1221.
Crossref
Jana L. Wardian, Joshua Tate, Irene Folaron, Sky Graybill, Mark True & Tom Sauerwein. (2018) Who’s distressed? A comparison of diabetes-related distress by type of diabetes and medication. Patient Education and Counseling 101:8, pages 1490-1495.
Crossref
Jennica Nichols, Michael Vallis, Stephanie Boutette, Carolyn Gall Casey & Catherine H. Yu. (2018) A Canadian Cross-Sectional Survey on Psychosocial Supports for Adults Living With Type 1 or 2 Diabetes: Health-Care Providers' Awareness, Capacity and Motivation. Canadian Journal of Diabetes 42:4, pages 389-394.e2.
Crossref
Timothy M.E. Davis, David G. Bruce, Bradley H. Curtis, Helen Barraclough & Wendy A. Davis. (2018) The relationship between intensification of blood glucose-lowering therapies, health status and quality of life in type 2 diabetes: The Fremantle Diabetes Study Phase II. Diabetes Research and Clinical Practice 142, pages 294-302.
Crossref
Samaneh Kalirai, Judith Stephenson, Magaly Perez-Nieves, Michael Grabner, Irene Hadjiyianni, Caroline Geremakis, Roy Daniel Pollom, Beverly Reed & Lawrence Fisher. (2018) Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitus. Primary Care Diabetes 12:2, pages 155-162.
Crossref
David J. Robinson, Michael Coons, Heidi Haensel, Michael Vallis & Jean-François Yale. (2018) Diabetes and Mental Health. Canadian Journal of Diabetes 42, pages S130-S141.
Crossref
Wen Xu, David Owens & Jianping Weng. 2018. Endocrine and Metabolic Medical Emergencies. Endocrine and Metabolic Medical Emergencies 548 559 .
Jane K. Dickinson, Susan J. Guzman, Melinda D. Maryniuk, Catherine A. O’Brian, Jane K. Kadohiro, Richard A. Jackson, Nancy D’Hondt, Brenda Montgomery, Kelly L. Close & Martha M. Funnell. (2017) The Use of Language in Diabetes Care and Education. Diabetes Care 40:12, pages 1790-1799.
Crossref
Jane K. DickinsonSusan J. GuzmanMelinda D. MaryniukCatherine A. O’BrianJane K. KadohiroRichard A. JacksonNancy D’HondtBrenda MontgomeryKelly L. CloseMartha M. Funnell. (2017) The Use of Language in Diabetes Care and Education. The Diabetes Educator 43:6, pages 551-564.
Crossref
Elizabeth Holmes-Truscott, John Furler, Irene Blackberry, David N. O'Neal & Jane Speight. (2017) Predictors of insulin uptake among adults with type 2 diabetes in the Stepping Up Study. Diabetes Research and Clinical Practice 133, pages 204-210.
Crossref
David R. Owens, Louis Monnier & Anthony H. Barnett. (2017) Future challenges and therapeutic opportunities in type 2 diabetes: Changing the paradigm of current therapy. Diabetes, Obesity and Metabolism 19:10, pages 1339-1352.
Crossref
Jianping Weng. (2017) Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9%. Journal of Diabetes 9:10, pages 890-893.
Crossref
E. Holmes-Truscott, F. Pouwer & J. Speight. (2017) Assessing Psychological Insulin Resistance in Type 2 Diabetes: a Critical Comparison of Measures. Current Diabetes Reports 17:7.
Crossref
Charles G. TaylorJr.Jr., Gordon Taylor, Anique Atherley, Ian Hambleton, Nigel Unwin & O. Peter Adams. (2017) The Barbados Insulin Matters (BIM) study: Barriers to insulin therapy among a population-based sample of people with type 2 diabetes in the Caribbean island of Barbados. Journal of Clinical & Translational Endocrinology 8, pages 49-53.
Crossref
Jason Chan & Angela Cheng-Lai. (2017) Inhaled Insulin. Cardiology in Review 25:3, pages 140-146.
Crossref
Nancy A. Allen, Sofija E. Zagarins, Rebecca G. Feinberg & Garry Welch. (2017) Treating psychological insulin resistance in type 2 diabetes. Journal of Clinical & Translational Endocrinology 7, pages 1-6.
Crossref
Abdulaziz Bin rsheed & Ian Chenoweth. (2017) Barriers that practitioners face when initiating insulin therapy in general practice settings and how they can be overcome. World Journal of Diabetes 8:1, pages 28.
Crossref
Christopher G. ParkinAnita HombergRolf Hinzmann. (2016) 9th Annual Symposium on Self-Monitoring of Blood Glucose, April 28–30, 2016, Madrid, Spain. Diabetes Technology & Therapeutics 18:11, pages 727-747.
Crossref
Janet B. McGill, David Ahn, Steven V. Edelman, C. Rachel Kilpatrick & Tricia Santos Cavaiola. (2016) Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?. Advances in Therapy 33:8, pages 1267-1278.
Crossref
Elizabeth Holmes-Truscott, Irene Blackberry, David N. O’Neal, John S. Furler & Jane Speight. (2016) Willingness to initiate insulin among adults with type 2 diabetes in Australian primary care: Results from the Stepping Up Study. Diabetes Research and Clinical Practice 114, pages 126-135.
Crossref
E. Holmes-Truscott, T.C. Skinner, F. Pouwer & J. Speight. (2016) Explaining psychological insulin resistance in adults with non-insulin-treated type 2 diabetes: The roles of diabetes distress and current medication concerns. Results from Diabetes MILES—Australia. Primary Care Diabetes 10:1, pages 75-82.
Crossref
Jianping Weng, Ravi Retnakaran, Ammini Ariachery C, Linong Ji, Luigi Meneghini, Wenying Yang & Jeong‐Taek Woo. (2014) Short‐term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gaps. Diabetes/Metabolism Research and Reviews 31:6, pages 537-544.
Crossref
Amitjeet Sahnan & Scot H. Simpson. (2015) Effect of an Experiential Exercise in Diabetes Management on Pharmacy Students’ Fear and Perceived Pain of Injection and Fingertip Lancing. American Journal of Pharmaceutical Education 79:1, pages 05.
Crossref
A. Jones, M. Vallis & F. Pouwer. (2015) If it does not significantly change HbA 1c levels why should we waste time on it? A plea for the prioritization of psychological well-being in people with diabetes . Diabetic Medicine 32:2, pages 155-163.
Crossref
John Furler, Irene Blackberry, Jo-Anne Manski-Nankervis, David O’Neal, James Best & Doris Young. (2015) Optimizing Care and Outcomes for People with Type 2 Diabetes – Lessons from a Translational Research Program on Insulin Initiation in General Practice. Frontiers in Medicine 1.
Crossref
Ye An KimWon Sang YooEun Shil HongEu Jeong KuKyeong Seon ParkSoo LimYoung Min ChoKyong Soo ParkHak Chul JangSung Hee Choi. (2015) Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin. Diabetes & Metabolism Journal 39:6, pages 489.
Crossref
J. L. Browne, G. Nefs, F. Pouwer & J. Speight. (2015) Depression, anxiety and self-care behaviours of young adults with Type 2 diabetes: results from the International Diabetes Management and Impact for Long-term Empowerment and Success (MILES) Study. Diabetic Medicine 32:1, pages 133-140.
Crossref
John S Furler, Doris Young, James Best, Elizabeth Patterson, David O’Neal, Danny Liew, Jane Speight, Leonie Segal, Carl May, Jo-Anne Manski-Nankervis, Elizabeth Holmes-Truscott, Louise Ginnivan & Irene D Blackberry. (2014) Can primary care team-based transition to insulin improve outcomes in adults with type 2 diabetes: the stepping up to insulin cluster randomized controlled trial protocol. Implementation Science 9:1.
Crossref
Hua Heng McVin Cheen, Seng Han Lim, Ming Chien Huang, Yong Mong Bee & Hwee Lin Wee. (2014) Adherence to Premixed Insulin in a Prefilled Pen Compared With a Vial/Syringe in People With Diabetes in Singapore. Clinical Therapeutics 36:7, pages 1043-1053.
Crossref
Kamlesh Khunti, Jiten Vora & Melanie Davies. (2014) Results from the UK cohort of SOLVE: Providing insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. Primary Care Diabetes 8:1, pages 57-63.
Crossref
W. Polonsky, L. Traylor, W. Wei, R. Shi, B. Ameer, A. Vlajnic & A. Nicolucci. (2014) More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 16:3, pages 255-261.
Crossref
Frank J. Snoek, Tibor R.S. Hajos & Stefanie M.P.A. Rondags. 2014. Hypoglycaemia in Clinical Diabetes. Hypoglycaemia in Clinical Diabetes 323 333 .
Elizabeth Holmes-Truscott, Frans Pouwer & Jane Speight. (2014) Further investigation of the psychometric properties of the insulin treatment appraisal scale among insulin-using and non-insulin-using adults with type 2 diabetes: results from diabetes MILES – Australia. Health and Quality of Life Outcomes 12:1, pages 87.
Crossref
Frank PetrakStephan HerpertzElmar StriddeAndreas Pfützner. (2013) Reply to “Comments on Petrak et al.'s ‘Psychological Insulin Resistance in Type 2 Diabetes Patients Regarding Oral Antidiabetes Treatment, Subcutaneous Insulin Injections, or Inhaled Insulin’: Considerations for Language and Communication”. Diabetes Technology & Therapeutics 15:12, pages 1055-1056.
Crossref
Sau Nga Fu, Weng Yee Chin, Carlos King Ho Wong, Vincent Tok Fai Yeung, Ming Pong Yiu, Hoi Yee Tsui & Ka Hung Chan. (2013) Development and Validation of the Chinese Attitudes to Starting Insulin Questionnaire (Ch-ASIQ) for Primary Care Patients with Type 2 Diabetes. PLoS ONE 8:11, pages e78933.
Crossref
K. Rascati, K. Richards, D. Lopez, L.-I. Cheng & J. Wilson. (2013) Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database. Diabetes, Obesity and Metabolism 15:10, pages 901-905.
Crossref
N. A. Lakkis, G. J. Maalouf, D. M. Mahmassani & G. N. Hamadeh. (2013) Insulin therapy attitudes and beliefs of physicians in Middle Eastern Arab countries. Family Practice 30:5, pages 560-561.
Crossref
Frank PetrakStephan HerpertzElmar StriddeAndreas Pfützner. (2013) Psychological Insulin Resistance in Type 2 Diabetes Patients Regarding Oral Antidiabetes Treatment, Subcutaneous Insulin Injections, or Inhaled Insulin. Diabetes Technology & Therapeutics 15:8, pages 702-710.
Crossref
Suman Machinani, Shahrzad Bazargan-Hejazi & Stanley H. Hsia. (2013) Psychological insulin resistance among low-income, U.S. racial minority patients with type 2 diabetes. Primary Care Diabetes 7:1, pages 51-55.
Crossref
G. Grunberger. (2013) The need for better insulin therapy. Diabetes, Obesity and Metabolism 15:s1, pages 1-5.
Crossref
Thomas Haak. (2012) Initial Combination with Linagliptin and Metformin in Newly Diagnosed Type 2 Diabetes and Severe Hyperglycemia. Advances in Therapy 29:12, pages 1005-1015.
Crossref
Ronnie Aronson. (2012) The Role of Comfort and Discomfort in Insulin Therapy. Diabetes Technology & Therapeutics 14:8, pages 741-747.
Crossref
K. Khunti, T. Damci, L. Meneghini, C. Y. Pan & J.‐F. Yale. (2012) Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. Diabetes, Obesity and Metabolism 14:7, pages 654-661.
Crossref
T. Haak, T. Meinicke, R. Jones, S. Weber, M. von Eynatten & H.‐J. Woerle. (2012) Initial combination of linagliptin and metformin improves glycaemic control in type 2 diabetes: a randomized, double‐blind, placebo‐controlled study. Diabetes, Obesity and Metabolism 14:6, pages 565-574.
Crossref
Timothy S. Bailey. (2012) Analysis and Perspective: Comparison of Insulin Diluent Leakage Post-Injection Using Two Different Needle Lengths and Injection Volumes in Obese Patients with Type 1 or Type 2 Diabetes Mellitus. Journal of Diabetes Science and Technology 6:2, pages 394-395.
Crossref
Jack L. Leahy. (2012) Insulin Therapy in Type 2 Diabetes Mellitus. Endocrinology and Metabolism Clinics of North America 41:1, pages 119-144.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.